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ATG16L1 governs placental infection risk 
and preterm birth in mice and women
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1Department of Obstetrics and Gynecology and 2Department of Pathology and Immunology, Washington University School 
of Medicine, St. Louis, Missouri, USA.
Introduction
Preterm birth (PTB), a leading global cause of perinatal morbidity and mortality, is commonly associated with 
intrauterine and placental infections. Normally, the placenta serves as a formidable barrier to protect the fetus 
from maternal-fetal transmission of pathogens, such as Listeria monocytogenes and Toxoplasma gondii (1, 2). The 
placental cells that facilitate this protection are the fetal syncytiotrophoblasts (STBs) in the syncytium that cov-
ers the villous surface of the placenta and, being in direct contact with maternal blood, helps form the mater-
nal-fetal blood barrier. STBs are derived from differentiation and fusion of highly proliferative cytotrophoblasts 
(CTBs), which stem from the trophectoderm (3). A third type of trophoblasts, extravillous trophoblasts (EVTs), 
extravasate from the villi, remodel the maternal spiral arteries, and invade the maternal interface to facilitate 
maternal blood flow to the growing fetus. We and others have shown that STBs are less susceptible to infection 
than CTBs and EVTs (4, 5), but the mechanism underlying this differential susceptibility is unknown.
An important part of  the host immune response to microbial infection is the cellular recycling system 
autophagy. During autophagy, double-membrane vesicles, termed autophagosomes, form around cytoplas-
mic debris, organelles targeted for destruction, and pathogens and then deliver their contents to lysosomes 
for degradation (6–8). Upon autophagosome formation, microtubule-binding protein light chain 3 (LC3) 
converts from the soluble form LC3-I to the lipidated form LC3-II; thus, the level of  LC3-II is an indicator 
of  autophagic activity, or flux, in cells. LC3-II levels are higher in placentas from pregnancies complicated 
by preeclampsia (9) and intrauterine fetal growth restriction (10), suggesting that autophagy plays a role 
in placental function. Autophagy-related 16-like 1 (ATG16L1), a ubiquitin ligase critical for autophago-
some closure, is a key player in regulating the autophagic response to pathogens (7). Additionally, a com-
mon polymorphism in ATG16L1 (rs2241880, Thr300Ala) that impairs its autophagy function is associated 
with rapid labor progression in pregnant women (11). However, whether autophagic flux in general, and 
ATG16L1 in particular, contributes to placental susceptibility to infection and PTB is unknown.
Here, we demonstrate that decreased autophagy in human placentas is associated with early PTB and 
that autophagic activity is normally high in STBs and is a key mechanism driving the antibacterial defense 
The placenta is a barrier against maternal-fetal transmission of pathogens. Placental infections 
can cause several adverse pregnancy outcomes, including preterm birth (PTB). Yet, we have limited 
knowledge regarding the mechanisms the placenta uses to control infections. Here, we show that 
autophagy, a cellular recycling pathway important for host defense against pathogens, and the 
autophagy gene Atg16L1 play a key role in placental defense and are negatively associated with 
PTB in pregnant women. First, we demonstrate that placentas from women who delivered preterm 
exhibit reduced autophagy activity and are associated with higher infection indicators. Second, 
we identify the cellular location of the autophagy activity as being in syncytial trophoblasts. 
Third, we demonstrate that higher levels of autophagy and ATG16L1 in human trophoblasts were 
associated with increased resistance to infection. Accordingly, loss of autophagy or ATG16L1 
impaired trophoblast antibacterial defenses. Fourth, we show that Atg16l1-deficient mice gave 
birth prematurely upon an inflammatory stimulus and their placentas were significantly less 
able to withstand infection. Finally, global induction of autophagy in both mouse placentas and 
human trophoblasts increased infection resistance. Our study has significant implications for 
understanding the etiology of placental infections and prematurity and developing strategies to 
mitigate placental infection–induced PTB.
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mechanisms in the syncytium. Additionally, we show in mice that ATG16L1 is required to combat placen-
tal infection and that reduced expression of  ATG16L1 leads to PTB and increased infection susceptibility 
in atg16l1-deficient placentas. Together, our findings provide a regulatory link among placental infection, 
autophagy, and PTB.
Results
Premature birth is associated with decreased autophagy and ATG16L1 expression in the placenta. We collected 
placental samples from a cross-sectional cohort of  40 pregnancies from a single tertiary care hospital. 
Pregnant subjects were divided into three groups based on gestational age at delivery: early preterm (<32 
weeks), late preterm (32–37 weeks), and term (>37 weeks) (Supplemental Table 1; supplemental mate-
rial available online with this article; doi:10.1172/jci.insight.86654DS1). We examined the relationship 
between gestational age at birth and levels of  autophagy as well as the association with white blood cell 
counts, a strong indicator of  subclinical and clinical infections (12). To compare levels of  autophagy 
among the three groups, we stained all placentas for LC3 and P62 (also known as SQSTM1), a linker 
protein that binds to ubiquitinated aggregates and targets them for degradation in the autolysosome (13). 
With increased autophagy, LC3-II levels increase and P62 levels decrease as P62-decorated organelles are 
degraded. Independent blinded quantification of  immunohistochemical staining revealed that LC3 abun-
dance was lower and P62 was higher in early preterm placentas than in late preterm and term placentas 
(Figure 1, A and B). Immunoblot analysis confirmed that P62 was higher and the LC3-II form of  LC3 
was lower in early preterm placentas than in late preterm and term placentas (Figure 1, C–E). The reduced 
level of  autophagy in early preterm placentas was likely not simply due to low gestational age, as a study 
by Hung et al. showed that LC3-II and BECLIN-1 were expressed at all gestational ages (15 weeks to 40 
weeks), and expression levels did not differ by gestational age (14). Thus, proper autophagy flux appears 
to be altered in early preterm placentas.
To further test this idea, we examined whether expression of  key autophagy pathway genes or pro-
teins differed in the preterm and term placentas. The canonical autophagy sequence involves assembly of  
autophagy-related proteins into complexes that are essential for steps of  autophagosome formation. We 
found that protein levels of  BECLIN-1 (involved in autophagy initiation) and ATG7 (involved in autopha-
gosomal membrane elongation) did not significantly differ among early preterm, late preterm, and term 
placentas (Figure 1, C, F, and G). However, the average level of  ATG16L1 was significantly lower in early 
and late preterm placentas than in term placentas (Figure 1H). Real-time quantitative PCR demonstrated 
that ATG16L1 mRNA levels positively correlated with LC3 mRNA levels (Supplemental Figure 1). Thus, 
ATG16L1 abundance correlates with autophagic activity in early preterm placentas.
From the clinical data on the patients, we observed that white blood cell counts, a strong indicator of  
subclinical and clinical intra-amniotic infections in PTB (12), were significantly higher in the women who 
delivered early preterm than in those who delivered late preterm or at term (Figure 1I and Supplemental 
Table 1). Notably, this was the case even though the percentage of  women treated with antibiotics did not 
differ significantly in the three groups (Supplemental Table 1). Together, our findings suggest that a low 
level of  autophagy, decreased expression of  ATG16L1, and possibly subclinical infection in the placenta 
are associated with early PTB.
Differential resistance in placental trophoblasts to infection is regulated by autophagy. Previously, we and 
others showed that trophoblast subtypes exhibit differential susceptibility to infection (4, 5). Given 
the link between autophagy and possible infection in preterm placentas, we reasoned that differential 
autophagy activation could underlie the differential susceptibility to infection in STBs and CTBs. To 
address this possibility, we performed immunocytochemistry of  normal term human placenta samples 
and found that STBs expressed more LC3 than CTBs did (Figure 2A), suggesting that autophagy levels 
positively correlated with syncytialization. To further test this idea, we examined the levels of  LC3-II 
and P62 in a well-established human choriocarcinoma cell line, BeWo, which is CTB-like and can be 
induced with forskolin to fuse to and form STBs (15). In BeWo cells, the level of  LC3-II increased 
during the 72-hour time course of  forskolin treatment (Figure 2B), confirming the positive correlation 
between autophagy activity and syncytialization. Finally, we found by immunofluorescence that BeWo 
STBs contained more LC3 punctae than CTBs, indicating increased LC3 lipidation and autophagy in 
STBs (Figure 2C). As an additional control to demonstrate that this phenomenon occurs in normal 
human trophoblasts, we isolated human primary mononucleated trophoblasts (PHTs) from normal full-
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term placentas. PHTs spontaneously form multinucleated STBs after 48 hours in culture. We found that 
P62 levels were lower in PHT-derived STBs than in CTBs (Supplemental Figure 2). To confirm that this 
finding indicated increased autophagic flux in STBs, we treated both cell types with bafilomycin, which 
inhibits autophagosome-lysosome fusion and thus stabilizes LC3-II. As anticipated, we found higher 
levels of  LC3-II in STBs (Supplemental Figure 2). Together, our data suggest that autophagy activity 
increases during trophoblast syncytialization.
Because autophagy is a vital part of  the host response to infection in many cell types, we wanted 
to determine whether basal autophagy affected the trophoblast response to bacterial infection. We first 
infected CTBs and STBs with pathogenic E. coli and examined intracellular bacterial localization per cell 
by immunofluorescence staining (Figure 3A) and quantified bacterial load using colony-forming units 
Figure 1. Autophagic activity is increased in preterm placentas. (A) Representative images of immunohistochemical staining of LC3 and P62 in placentas 
of early preterm (n = 10), late preterm (n = 10), and term deliveries (n = 20). Scale bar: 200μm. (B) Quantification of LC3 and P62 immunohistochemical 
staining. Staining images were examined and scored in a blinded fashion. Intensity of staining was scored from 1 (low) to 5 (high, P62) or 6 (high, LC3). (C) 
Western blot analysis of LC3-II, P62, ATG7, ATG16L1, BECLIN-1, and ACTIN from human placental samples from the indicated groups. (D–H) Quantification 
of indicated autophagy proteins normalized to ACTIN. (I) White blood cell (WBC) counts of patients in indicated groups. Data are expressed as mean ± 
SEM in B–I. *P < 0.05, **P < 0.01 using Kruskal-Wallis test with Dunnett’s post-test.
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(Figure 3B). We found that STBs contained significantly fewer intracellular bacteria than CTBs (Figure 
3, A and B). Next, we treated the cells with an inducer, rapamycin, or inhibitor, 3-MA, of  autophagy. As 
expected, rapamycin-treated CTBs and STBs both exhibited higher levels of  LC3-II than DMSO-treated 
controls, and 3-MA–treated STBs had lower levels of  LC3 II than control, DMSO-treated STBs (Fig-
ure 3C). This higher level of  autophagy in STBs than in CTBs was maintained even upon bafilomycin 
treatment, indicating that it was not caused by impaired autolysosomal degradation (Figure 3C). Trans-
mission electron microscopy (TEM) was performed and revealed that rapamycin treatment increased 
double-membraned autophagosome formation in CTBs, whereas 3-MA–treated CTBs had fewer fully 
developed autophagosome structures (Supplemental Figure 3).
We next examined bacterial load in these cells and found that rapamycin-treated CTBs and STBs both 
harbored lower intracellular bacterial burden than untreated cells, although CTBs still contained more bac-
teria than STBs (Figure 3D). Conversely, 3-MA treatment did not change the intracellular bacterial load in 
CTBs but did increase the bacterial load in STBs (Figure 3D). TEM analysis provides further evidence of  
direct interaction between bacteria and autophagosomes in trophoblasts (Supplemental Figure 3). Togeth-
er, these data suggest that autophagy activity in placental cells is inversely correlated with susceptibility to 
bacterial infection and inhibition of  autophagy impairs STB antibacterial defenses.
Loss of  ATG16L1 impaired antibacterial defenses in human and mouse placentas. We noted above that early 
preterm human placentas, which came from women with high white blood cell counts, had higher levels 
of  ATG16L1 than term placentas. Moreover, examination of  specific autophagy proteins revealed that 
levels of  ATG16L1, but not ATG7 or BECLIN-1, were higher in STBs than CTBs (Figure 4A). To assess 
the requirement for ATG16L1 in governing STB resistance to infection, we used gene-specific siRNAs 
to knock down expression of  ATG16L1. We found that loss of  ATG16L1 increased STB susceptibility to 
infection (Figure 4, B and C). Loss of  ATG16L1 in CTBs, however, did not alter CTB susceptibility to 
infection (data not shown). These data indicate that ATG16L1 is an important component of  STB resis-
tance to bacterial infection.
To further assess the requirement for ATG16L1 in protecting the placental syncytium from infection, 
we used Atg16L1-hypomorphic (Atg16L1HM) mice, which display compromised autophagic activity in 
numerous tissues but no obvious phenotypic abnormalities in the absence of  infection/injury (16). Mice 
heterozygous for Atg16L1HM were bred to generate pups and placentas with three genotypes: WT, heterozy-
gous (HET), and homozygous (HM) (Figure 5A). Breeders gave birth to pups in normal Mendelian ratios, 
and placental and fetal weights were similar among the three genotypes (Supplemental Figure 4, A–C). 
Furthermore, the HM placentas exhibited normal histological structure, with similar thickness of  the three 
functional layers — decidua, junctional zone, and labyrinth — as WT placentas (Supplemental Figure 4D). 
As expected, HET and HM placentas expressed less ATG16L1 protein than WT littermate placentas (Fig-
ure 5B). P62 levels were higher in both HM and HET placentas than in WT placentas, suggesting that even 
intermediate ATG16L1 deficiency can impair autophagy flux (Supplemental Figure 5). We conclude that 
ATG16L1 is necessary for autophagic activity in the placenta.
Figure 2. The baseline level of autophagy is higher in syncytialized than nonsyncytialized human trophoblasts. (A) Immunohistochemical staining 
of LC3 in a representative human term placental villus sample. Scale bar: 100 μm. Inset bar: 10 μM. (B) Western blot detection and quantification of LC3 
levels in BeWo CTBs and STBs. (C) Immunofluorescent localization of the autophagy marker LC3 (green punctae) (arrow). Dashed line outlines STBs, solid 
lines outline CTBs. Blue, DAPI. Scale bar: 10 μm. Data are expressed as mean ± SEM.*P < 0.05 using Kruskal-Wallis test with Dunnett’s post-test.
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To elucidate whether ATG16L1 was also necessary for placental defense against bacterial pathogens, 
we developed an ex vivo mouse placental explant model that exhibits normal morphology and expression 
of  the placental epithelial maker cytokeratin 7 (Supplemental Figure 6). We challenged explants of  WT, 
HET, and HM littermate placentas with pathogenic E. coli and found that HM and HET placental explants 
both harbored significantly higher intracellular bacterial loads than WT explants (Figure 5C). We won-
dered whether higher sensitivity to bacterial infection in Atg16L1-deficient placentas was caused by com-
promised canonical autophagy or whether it could be rescued by induction of  autophagic flux. Thus, we 
pretreated placental explants with rapamycin to globally induce autophagy, which we confirmed by exam-
ining P62 and LC3-II levels (Figure 5D). Upon rapamycin treatment, the numbers of  intracellular bacteria 
in HM and HET placentas were reduced to levels similar to those in WT placentas (Figure 5E). Together, 
these findings suggest that ATG16L1 and the autophagy pathway in general contribute to protecting the 
placenta against bacterial infection.
ATG16L1-deficient mice exhibit increased sensitivity to inflammation-induced PTB. Our human placental stud-
ies described in Figure 1 suggested that premature placentas expressed lower levels of  ATG16L1 than term 
placentas. Thus, we asked whether loss of  Atg16L1 would trigger spontaneous PTB in pregnant mouse 
dams. We crossed WT, HET, and HM females to males of  the same respective genotypes and observed no 
differences in gestational length, indicating that Atg16l1 deficiency alone did not trigger spontaneous PTB 
(Figure 5F). We wondered whether inflammation would synergize with loss of  Atg16L1 to trigger PTB. 
Thus, we injected dams on day 15.5 of  pregnancy with LPS, which is often used to induce inflammation 
in animal models of  infection/inflammation-induced PTB (17). Whereas mice of  all three genotypes gave 
birth within 24 hours after treatment with a high dose (50 μg) of  LPS, only HET and HM mice delivered 
prematurely when given a lower dose of  LPS (10 μg) (Figure 5F). Together, these findings suggest that loss 
or dysfunction in Atg16L1 can lead to increased sensitivity to inflammation-triggered PTB.
Figure 3. Autophagy contributes to STB resistance to bacterial colonization. (A) Immunofluorescence microscopy of CTBs (BeWo) and STBs (forsko-
lin-treated BeWo) exposed to E. coli (red). STBs are marked by expression of human chorionic gonadotropin β subunit (hCG b, green), and cell membranes 
were marked by E-cadherin (magenta). The number of intracellular E. coli per trophoblast cell nucleus is shown. n = 200 nuclei/group. ***P < 0.001 by 
Mann-Whitney U test. (B) Number of intracellular E. coli determined by counting colony-forming units in STBs relative to CTBs (set at 100%). ***P < 
0.001 by Mann-Whitney U test. (C) Western blot detection of LC3 in DMSO-, rapamycin- (Rap-), and 3-MA–treated CTBs and STBs. Bafilomycin (Baf) 
treatment indicates that enhanced LC3 activity is due to autophagic flux. (D) CFU analysis of intracellular bacteria number in CTBs upon rapamycin and 
3-MA treatment. CFU counts were compared with DMSO-treated CTBs. Scale bar: 50 μm. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01 using 
Kruskal-Wallis test with Dunnett’s post-test.
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Discussion
Autophagy is a vital part of  the host immune response that delivers intracellular pathogens to lysosomes, 
thereby eliminating them. However, the role of  autophagy in protection from bacterial pathogens in the 
placenta was hitherto poorly understood. Here, we show that autophagy protects the placenta from bacte-
rial infection, and levels of  autophagy at least partly explain the differential susceptibility of  trophoblast 
types to bacterial challenge. We conclude that, in addition to their dense and branched microvilli, lack of  
intercellular junctions, and dense physical actin network (18), STBs use autophagy to combat bacterial 
infections. The placenta is an immunoprivileged organ that protects the fetus from both maternal immune 
rejection and pathogen challenge. However, several of  the pathogens that can infect the placenta, such 
as B. abortus (19), C. burnetii (20), and L. monocytogenes (21), can evade or subvert the autophagic cellular 
machinery to survive intracellularly in other cell types (22). Thus, high levels of  autophagy in the placenta 
may explain why transplacental infections are rare even for autophagy-hijacking pathogens. Recent work 
from our laboratory has demonstrated that the emerging virus, Zika, can be successfully transmitted from 
mother to fetus in a transplacental manner via trophoblasts (23–25). It remains to be determined whether 
the Zika virus is able to cross the placenta by modifying autophagy.
Previous studies have suggested that autophagy is regulated during human pregnancy, especially during 
placental distress as a higher level of  autophagy was observed in placentas from cesarean-sectioned moth-
ers versus those that delivered vaginally (26). Higher placental autophagy activity has been associated with 
development of  preeclampsia (9) and intrauterine growth restriction (10). Thus, although our studies sug-
gest an important role for higher autophagic activity level in the placental syncytium in terms of  host 
defense, there appears to be a complicated relationship between autophagy activity regulation and preg-
nancy outcomes in general. The precise mechanisms of  spatial and temporal regulation by autophagy in 
pregnancy, placental infections, and noninfectious conditions needs be further investigated.
We have shown that loss of  Atg16L1 protects mice against infections (27) of  the urinary tract and the 
intestine (28). However, Atg16L1 deficiency in many other tissues leads to increased susceptibility to infec-
tion (29, 30). The data presented here show that the role of  Atg16L1 in the placenta is more similar to that 
in those other tissues, with loss of  the gene leading to increased susceptibility to bacterial infection. Hence, 
this is further confirmation that the roles of  ATG16L1 in bacterial infections are tissue dependent. Consis-
tent with the idea that ATG16L1 plays an important role in placental function, women with the Thr300Ala 
(rs2241880) single nucleotide polymorphism in the ATG16L1 gene had shorter induction times during labor 
than women with two other ATG16L1 genotypes (11). This finding raises the possibility that regulation of  
ATG16L1 affects labor timing in humans.
Even in the absence of  infection, autophagy appears to be involved in birth timing in mice. For exam-
ple, ovarian granulosa cell–specific Beclin-1 knockout mice exhibit impaired lipid droplet formation and 
significantly reduced progesterone synthesis, which leads to PTB (31). Additionally, treatment with rapa-
mycin abolished preterm labor in an animal model of  spontaneous PTB, namely P53 conditional knockout 
mice (32). Finally, dysregulation of  autophagy has recently been shown in a mouse model of  inflamma-
tion-induced preterm labor (33).
Figure 4. ATG16L1 in STBs regulates resistance to infection. (A) Western blot detection of autophagy proteins ATG16L1, ATG7, BECLIN-1 and LC3 in 
BeWo CTBs and STBs and quantification of ATG16L1 protein levels in CTBs and STBs. Mean values ± SEM of 3 independent experiments. (B) Western 
blot detection of ATG16L1 in STBs after exposure to control or ATG16L1-specific siRNA. (C) Quantification of bacterial load in STBs treated with control or 
ATG16L1-specific siRNA. The graph shows mean values ± SEM of 4 independent experiments. *P < 0.05, **P < 0.01 by Mann-Whitney U test.
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Infection and inflammation are thought to be the most important triggers for PTB. Our work provides the 
first evidence to our knowledge that autophagy activity and ATG16L1 expression are reduced in early preterm 
placentas. These placentas came from women with increased white blood cell counts, suggesting that loss or 
dysfunction of ATG16L1 can synergize with inflammation, and possibly infection, to cause PTB. This idea is 
consistent with our observation that Atg16L1HM mice only delivered preterm when also treated with LPS and 
indicative of gene-environment interactions at play in determining the threshold for adverse birth outcomes. 
We suggest that because autophagy is a vital part of the host response to microbial infection and can directly 
eliminate intracellular pathogens by mediating their delivery to lysosomes, infection is a driving factor for high 
autophagic activity in the placenta. Thus, we must keep in mind that dysfunction or modulation of autophagy 
in response to a pathogen may play a role in PTB that is equal in importance to infection itself.
Trophoblasts express pattern recognition receptors such as Toll-like receptors (TLRs) that can recog-
nize extrinsic microbial factors. TLR4 is the primary detector of  LPS on Gram-negative bacteria. Tro-
phoblasts also express intracellular receptors called Nod-like receptors (NLRs) that recognize bacterial 
products in the cytosol, and NLRs may serve as components of  inflammasomes, which are key signal-
ing complexes that detect pathogenic microorganisms and activate the highly proinflammatory cytokine 
IL-1β (34). Studies from our group and others have revealed that autophagy can dampen activation of  
the innate immune response to infection as well as activation of  inflammasomes, in particular NLRP3 (6, 
7, 35). Additionally, a recent study showed that exposing CTBs from first trimester placental samples to 
bacterial LPS upregulated NLRP3 expression and induced IL-1 β secretion, suggesting that the NLRP3 
inflammasome is important in placental innate immune responses (36). Thus, the complex process of  
labor and birth may represent a combinatorial confluence of  genetic and environmental causes. This idea 
has profound implications for how we view the relationship between genetic heterogeneity and PTB in 
humans and suggests that studies examining associations between prematurity and infections should also 
consider genetic variation. Further defining the roles of  autophagy and key autophagy genes in the pla-
centa will have significant implications for understanding the etiology of  placental infections and develop-
ing strategies to mitigate placental infection–induced PTB.
Figure 5. Atg16l1-deficient mice are susceptible to placental infection and LPS-induced preterm birth. (A) Schematic representation of mouse placental 
explant infections. (B) Western blot detection of ATG16L1 in placentas of the indicated genotype. (C) Quantification of intracellular E. coli load in placental 
explants of the indicated genotypes normalized to WT at 100%. *P < 0.05, **P < 0.01 by Kruskal-Wallis test with Dunnett’s post-test. (D) Western blot detec-
tion of LC3 and P62 in DMSO- and rapamycin-treated placental explants. (E) Quantification of intracellular E. coli load in DMSO- and rapamycin-treated WT, 
HET, and HM placental explants standardized to DMSO-treated WT. *P < 0.05 by Kruskal-Wallis test with Dunnett’s post-test. (F) Day of delivery in WT, HET, 
and HM mice injected with PBS or LPS on day 15.5 of pregnancy. Data are expressed as mean ± SEM. *P < 0.001 by 2-way ANOVA with a Bonferroni post-test.
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Methods
Human samples. Placental specimens were collected at Barnes-Jewish Hospital and processed through the 
Women and Infants’ Health Specimen Consortium. None of  the PTB patients showed clinical or patholog-
ical features of  other maternal or placental complications. Samples (5–8 mm) from the basal plate, chori-
onic villi, and amniotic membranes were obtained from placentas immediately after delivery. Tissues were 
processed as previously described (37).
Mouse husbandry. Atg16l1HM mice were provided by Herbert “Skip” Virgin (Washington University, St. 
Louis, Missouri, USA) (16). All mice were on a C57BL6 background and housed under a 12-hour-light/12-
hour dark cycle in a clean mouse breeding facility. For mating, 12- to 15-week-old male and nulliparous 
female mice were cohoused from 5:00 pm to 8:00 am, and day 1 of  pregnancy was defined on first obser-
vation of  a vaginal plug. Mouse placenta samples were collected at day 16.5 and processed as described 
below.
Analysis of  birth timing. Mice received intraperitoneal injection of  saline or LPS (10 μg or 50 μg) on day 
15.5 of  pregnancy. Parturition was monitored from day 15.5 through day 21.5. Birth timing was document-
ed upon delivery of  the first pup or first observation of  pups.
Cell lines. The human choriocarcinoma cell line BeWo (ATCC) was maintained at 37°C, 5% CO2, 
with DMEM/F12 (1:1) medium (Gibco) supplemented with 10% FBS (Life Technologies). For trophoblast 
syncytialization, BeWo cells seeded at 1.5 × 105 cells/well in 24-well plates were cultured in medium with 
DMSO (vehicle) or 50 mM forskolin (Sigma-Aldrich) for 72 hours.
Primary human trophoblasts were isolated from cesarean-sectioned singleton term placentas without 
pregnancy complications by using the trypsin-DNase-dispase/Percoll method described previously (38). 
To purify primary CTBs, the trophoblasts were grown in MEM supplemented with 10% FBS for 4 hours 
and then washed 3 times with PBS to remove the syncytial fragments, which have lower affinity for the 
culture dish. After 24 hours, primary CTBs were transferred to phenol red–free DMEM with 10% char-
coal-stripped FBS (Life Technologies) and continuously cultured for an additional 48 hours to induce dif-
ferentiation into multinucleated STBs.
Placental explants. Mouse placentas were harvested on day 16.5 of  gestation. The fetal compartments 
of  the placentas were carefully dissected from connecting maternal tissues, including the myometrium and 
decidua. Each placenta was cut in half, rinsed thoroughly in cold PBS, and dissected into approximately 
5-mm pieces. Mouse placental explants were seeded on collagen I–coated 12-well plates and cultured in 
DMEM with 10% FBS.
siRNA transfection of  STBs. BeWo cells were cultured in medium with forskolin for 24 hours and 
then transfected with siRNA-targeting ATG16L1 or control siRNA and Trans-X2 transfection reagent 
(Mirus). BeWo cells were grown in medium containing siRNA and forskolin for an additional 48 hours 
to form STBs.
Colony formation assay. Cell cultures were infected with a pathogenic E. coli clinical isolate, UTI89 (1 × 
108 CFU/ml), for 2 hours, treated with media containing gentamicin (50 μg/ml, Invitrogen) for 2 hours to 
kill extracellular bacteria, washed 3 times with PBS, and then lysed by the addition of  500 μl PBS with 0.1% 
Triton for 10 minutes. Cell lysates were transferred to 96-well plates, and serial dilutions of  each lysate were 
added to LB plates and incubated at 37°C overnight, after which colonies were counted.
Immunofluorescence microscopy. Cells cultured in Chamber Slides (Nunc) were fixed in 4% paraformal-
dehyde in PBS for 30 minutes at room temperature. Slides were stained for presence of  bacteria and other 
markers as described previously (5). The following primary antibodies were used: rabbit polyclonal anti-
body to E. coli (1:500, United States Biological, E3500-26) and mouse monoclonal antibody to E-cadherin 
(1:500, BD, 610181). After 3 PBS washes at room temperature, antigen-antibody complexes were detected 
with species-specific Alexa Fluor 488 and 594–conjugated secondary antibodies (1:500, Invitrogen). Slides 
were stained with DAPI for 10 minutes and mounted with Prolong Gold (Life Technologies). Images were 
obtained with a Zeiss Apotome microscope using ×20 or ×60 oil immersion objectives.
Hematoxylin and eosin staining and immunohistochemistry. Human and mouse placenta samples were 
fixed with 4% paraformaldehyde in PBS for 24 hours and then embedded in paraffin. For histology, 5-mm 
sections were stained with Mayer’s Hematoxylin and Eosin Y solutions (Sigma-Aldrich). Immunohisto-
chemistry was done as described previously (37). The following primary antibodies were used: anti-LC3 
(1:200; Novus, NB600-1384), anti-P62 (1:500; Santa Cruz Biotechnology, SC28359), and anti-cytokeratin 
(1:1,000; DAKO, Z0622).
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TEM. BeWo cells were prepared for TEM analysis as described previously (39). TEM sections were 
imaged using a JEOL 1200 EX transmission electron microscope (JEOL USA Inc.).
Western blotting. Total protein was extracted form frozen human and mouse placenta samples and 
homogenized in RIPA buffer (Cell Signaling Technology) with protease inhibitor cocktails (Sigma-Al-
drich). Equivalent amounts of  total protein, determined by BCA assays (Thermo Scientific), were sep-
arated on 4%–20% Mini-PROTEAN precast gels (Bio-Rad) and transferred to PVDF membranes. The 
following primary antibodies and dilutions were used: anti-LC3B (1:1,000; Novus, NB600-1384), anti-P62 
(1:1,000; Abcam, ab56416), anti-Atg7 (1:1,000; Sigma-Aldrich, A2856), anti-Atg16L1 (1:1,000; Sigma-Al-
drich, A7356), anti-Beclin1 (1:1,000; Cell Signaling, 3738s), and anti-Actin (1:2,000; Cell Signaling, 3700s). 
ImageJ (NIH) was used for densitometry of  Western blots.
Statistics. Data are presented as mean ± SEM. The Mann-Whitney U test was performed on compari-
sons between two groups, and the Kruskal-Wallis test was performed with Dunnett’s post-test for multiple 
comparisons. Two-way ANOVA with a Bonferroni post-hoc test was used for multiple pairwise compar-
isons between different groups. Graphpad Prism 5.0 was used for all analyses. P < 0.05 was considered 
significant.
Study approval. This study was approved by the Washington University School of  Medicine human 
studies review board (IRB ID 201012734). All animal procedures were reviewed and approved by the ani-
mal studies committee of  the Washington University School of  Medicine.
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